Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
2(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
7
70%
Ph phase_2
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
2(22.2%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(8)

Detailed Status

Completed8
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (22.2%)
N/A7 (77.8%)

Trials by Status

completed880%
recruiting220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10